Clinical Trial Update: Direct Oral Anticoagulants (Rivaroxaban and Apixaban) in Patients With Liver Cirrhosis [Phase 1]

View source ↗

Summary

Ongoing Phase 1 clinical trial evaluating direct oral anticoagulants rivaroxaban and apixaban in patients with liver cirrhosis (recruiting).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cirrhosis

Drugs mentioned

• Eliquis (apixaban)
• Xarelto (rivaroxaban)

Snippet

Sponsor: Insel Gruppe AG, University Hospital Bern | Conditions: Liver Cirrhosis | Phase 1 | Status: RECRUITING